You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

PTAB Cases from Pfizer, Inc.

✉ Email this page to a colleague

« Back to Dashboard

Patent Trial and Appeal Board Cases for Petitioner: Pfizer, Inc.

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Patent	Petitioner	Status	Filing Date	Accorded Filing Date	Patent Owner	Trial Type	Trial Number	Decision Date	Inventor	Document Download
7,332,289	Pfizer, Inc.	⤷ Start Trial	2017-05-19	05-19-2017		Inter partes review	⤷ Start Trial	12-01-2017		⤷ Start Trial
7,682,612	Pfizer, Inc.	⤷ Start Trial	2017-10-06	11-06-2017		Inter partes review	⤷ Start Trial	04-30-2018		⤷ Start Trial
7,820,161	Pfizer, Inc.	⤷ Start Trial	2017-03-24	03-24-2017		Inter partes review	⤷ Start Trial	07-18-2017		⤷ Start Trial
7,927,815	Pfizer, Inc.	⤷ Start Trial	2017-05-19	05-19-2017		Inter partes review	⤷ Start Trial	12-01-2017		⤷ Start Trial
7,976,838	Pfizer, Inc.	⤷ Start Trial	2017-08-29	08-29-2017	BENYUNES, MARK C.	Inter partes review	⤷ Start Trial	04-04-2018		⤷ Start Trial
>Patent	>Petitioner	>Status	>Filing Date	>Accorded Filing Date	>Patent Owner	>Trial Type	>Trial Number	>Decision Date	>Inventor	>Document Download

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.